Ameloblastic Fibroma Associated with an Impacted Mandibular Third Molar: A Case Report
DOI:
https://doi.org/10.5327/2525-5711.520Keywords:
Fibroma, Odontogenic Tumors, Oral Surgical Procedures, Mandibular Neoplasms, Radiography, PanoramicAbstract
Ameloblastic fibroma (AF) is a rare benign mixed odontogenic tumor that affects the jaws, most commonly occurring in the posterior region of the mandible. It predominantly affects individuals during the first two decades of life and is more prevalent in males. Histopathologically, AF is characterized by islands and cords of odontogenic epithelium embedded within an ectomesenchymal stroma resembling the dental papilla and enamel organ. This article reports the case of a 12-year-old female patient with albinism in whom a routine radiographic examination revealed a well-defined unilocular radiolucent lesion in the posterior right region of the mandible associated with an impacted third molar. Clinical examination revealed no facial asymmetry or buccal cortical expansion. The lesion was treated by excisional biopsy and enucleation, with preservation of the impacted tooth. Histopathological analysis confirmed the diagnosis of ameloblastic fibroma. The patient remains under clinical and radiographic follow-up, demonstrating progressive bone regeneration and preservation of tooth 48, with no evidence of recurrence 17 months after surgery. This case highlights the value of routine radiographic examination and conservative surgical management in young patients, allowing lesion removal while preserving the associated tooth and with favorable bone healing.
References
1. Pindborg JJ, Kramer IRH, Torloni H. International classification of tumors. No. 5. Geneva: World Health Organization; 1971.
2. López RMG, Ortega L, Corchón MAG, Sandéz AB. Ameloblastic fibroma of the mandible: report of two cases. Med Oral. 2003;8:150-3.
3. Chan JKC, El-Naggar AK, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours. Geneva: World Health Organization; 2017.
4. Alqhtani NR. Maxillary cystic ameloblastic fibroma in an 8-year-old girl: a case report featuring a rare histological variant. Case Rep Dent. 2025:7645367.
5. Kruse A. Über die Entwicklung cystischer Geschwülste im Unterkiefer. Arch Pathol Anat. 1891;124:137-48.
6. Chen Y, Wang JM, Li TJ. Ameloblastic fibroma: a review of published studies with special reference to its nature and biological behavior. Oral Oncol. 2007;43:960-9.
7. Reichart PA, Philipsen HP. Ameloblastic fibroma. In: Reichart PA, Philipsen HP, editors. Odontogenic tumors and allied lesions. London: Quintessence Publishing Co Ltd; 2004. p.121-8.
8. Cohen DM, Bhattacharyya I. Ameloblastic fibroma, ameloblastic fibro-odontoma, and odontoma. Oral Maxillofac Surg Clin North Am. 2004;16:375-84.
9. Bregni RC, Taylor AM, Garcia AM. Ameloblastic fibrosarcoma of the mandible: report of two cases and review of the literature. J Oral Pathol Med 2001;30:316-20.
10. Pitak-Arnnop P, Chaine A, Dhanuthai K, Bertrand JC, Bertolus C. Extensive ameloblastic fibroma in an adolescent patient: a case report with a follow-up of 4 years. Eur J Dent. 2009;3:224-8.
11. Gupta S, Tandon A, Mehrotra D, Gupta OP. Ameloblastic fibroma: report of 3 cases and literature review. Int J Oral Maxillofac Pathol. 2011;2:59-63.
12. Jindal C, Bhola RS. Ameloblastic fibroma in six-year-old male: hamartoma or a true neoplasm. J Oral Maxillofac Pathol. 2011;15:303-5.
13. Muller S, Parker DC, Kapadia SB, Budnick SD, Barnes EL. Ameloblastic fibrosarcoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 469–77.
14. Khande KC, Mograwala HJ, Halli RC, Hebbale MA. Ameloblastic fibroma mimicking dentigerous cyst: a diagnostic dilemma. Ann Maxillofac Surg. 2019;9:201-4.
15. Nelson BL, Folk GS. Ameloblastic fibroma. Head Neck Pathol. 2009;3:51-3.
16. Trodahl JN. Ameloblastic fibroma: a survey of cases from the Armed Forces Institute of Pathology. Oral Surg Oral Med Oral Pathol. 1972;33:547-58.
17. Vasconcelos BCE, Andrade ESS, Rocha NS, Morais HHA, Carvalho RWF. Treatment of large ameloblastic fibroma: a case report. J Oral Sci. 2009;51:293-6.
18. Roza ALOC, Shrestha M, Bezerra HKF, Fonsêca TC, Schouwstra CM, Smit C, et al. New insights into ameloblastic fibromas, fibrodentinomas, and fibro-odontomas: findings from an international multicenter study. Head Neck Pathol. 2025;19(1):57.
19. Regezi JA, Kerr DA, Courtney RM. Odontogenic tumors: analysis of 706 cases. Oral Surg Oral Med Oral Pathol. 1978;36:771-8.
20. Sanadi A, Shah SJ, Golgire S, Shetti S. Highly proliferative ameloblastic fibroma: a rare entity. Contemp Clin Dent. 2018;9:656-8.
21. Slootweg PJ. An analysis of the interrelationship of mixed odontogenic tumors: ameloblastic fibroma, ameloblastic fibro-odontoma, and the odontomas. Oral Surg Oral Med Oral Pathol. 1981;51:266-76.
22. Buchner A, Vered M. Ameloblastic fibroma: a stage in the development of a hamartomatous odontoma or a true neoplasm? Critical analysis of 162 previously reported cases plus 10 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:598-606.
23. Bhanu U, Kulkarni R, Boaz K, Srikant N. Pigmented odontogenic tumors: adding color to diagnosis? J Oral Maxillofac Pathol. 2014;18(3):398-402.
24. Kobayashi K, Murakami R, Fujii T, Hirano A. Malignant transformation of ameloblastic fibroma to ameloblastic fibrosarcoma: case report and review of the literature. J Craniomaxillofac Surg. 2005;33:352-5.
25. Tomich CE. Benign mixed odontogenic tumors. Semin Diagn Pathol. 1999;16:308-16.
26. Chrcanovic BR, Brennan PA, Rahimi S, Gomez RS. Ameloblastic fibroma and ameloblastic fibrosarcoma: a systematic review. J Oral Pathol Med. 2018;47:315-25.
27. Manzon S, Philbert RF, Bush BF, Zola MB, Solomon M. Treatment of a recurrent ameloblastic fibroma. N Y State Dent J. 2015;81:30-2.
28. Hansen LS, Ficara G. Mixed odontogenic tumors: analysis of 23 new cases. Head Neck Surg. 1988;10:330-43.
29. Marçon CR, Maia M. Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors. An Bras Dermatol. 2019;94(5):503-20
30. World Health Organization. WHO classification of head and neck tumours. Lyon (FR): International Agency for Research on Cancer; 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pryscilla Batista Leite, Vera Campos , Michele Machado Lenzi da Silva , Mirian de Waele Souchois de Marsillac, Fábio Ramoa Pires
This work is licensed under a Creative Commons Attribution 4.0 International License.
